Asbestos exposure and small cell lung cancer: Systematic review and meta-analysis

被引:4
|
作者
Curiel-Garcia, Teresa [1 ,2 ]
Rey-Brandariz, Julia [1 ]
Varela-Lema, Leonor [1 ,3 ,4 ]
Ruano-Ravina, Alberto [1 ,3 ,4 ]
Candal-Pedreira, Cristina [1 ,3 ]
Mourino, Nerea [1 ]
Moure-Rodriguez, Lucia [1 ,3 ,4 ]
Figueiras, Adolfo [1 ,3 ,4 ]
Perez-Rios, Monica [1 ,3 ,4 ]
机构
[1] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, C San Francisco S-N, Santiago De Compostela 15782, Spain
[2] Complejo Hosp Univ Santiago, Med Oncol, Santiago De Compostela, Spain
[3] Hlth Res Inst Santiago de Compostela, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela, Spain
[4] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Pamplona, Spain
关键词
Asbestos; carcinogens; lung neoplasms; occupational exposure; OCCUPATIONAL-EXPOSURE; RISK; HISTORIES; SMOKING; DISEASE;
D O I
10.1080/15459624.2023.2232421
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Asbestos is a mineral that is carcinogenic to humans. Its use has been banned in many occidental countries yet it is still produced in the United States, and materials that contain asbestos remain in many occupational settings and indoor environments. Even though asbestos carcinogenicity is well known, there is scant literature on its specific effects regarding small cell lung cancer (SCLC). We therefore conducted a systematic review and meta-analysis to determine SCLC risk among workers exposed to asbestos. A systematic search of the literature was conducted to identify studies which reported occupational exposure to asbestos and SCLC-related deaths and/or incidence. We identified seven case-control studies that included 3,231 SCLC cases; four studies reported smoking-adjusted risks. A significantly increased risk of SCLC (pooled OR 1.89; 95% CI, 1.25-2.86) was observed on pooling studies on men (six studies) that displayed moderate heterogeneity (I2 = 46.0%). Overall, our synthesis suggests that occupational exposure to asbestos significantly increases the risk of SCLC on men.
引用
收藏
页码:427 / 438
页数:12
相关论文
共 50 条
  • [41] Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Zeng, Haiyan
    Zheng, Danyang
    Witlox, Willem J. A.
    Levy, Antonin
    Traverso, Alberto
    Kong, Feng-Ming
    Houben, Ruud
    De Ruysscher, Dirk K. M.
    Hendriks, Lizza E. L.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
    Horita, Nobuyuki
    Yamamoto, Masaki
    Sato, Takashi
    Tsukahara, Toshinori
    Nagakura, Hideyuki
    Tashiro, Ken
    Shibata, Yuji
    Watanabe, Hiroki
    Nagai, Kenjiro
    Inoue, Miyo
    Nakashima, Kentaro
    Ushio, Ryota
    Shinkai, Masaharu
    Kudo, Makoto
    Kaneko, Takeshi
    SCIENTIFIC REPORTS, 2015, 5
  • [43] Amrubicin For Relapsed Small-Cell Lung Cancer: A Systematic Review And Meta-Analysis Of 803 Patients
    Nakashima, K.
    Horita, N.
    Narita, A.
    Ikeda, M.
    Ushio, R.
    Watanabe, H.
    Nagai, K.
    Shibata, Y.
    Tashiro, K.
    Nagakura, H.
    Tsukahara, T.
    Yamamoto, M.
    Sato, T.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [44] ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis
    Elliott, Jesse
    Bai, Zemin
    Hsieh, Shu-Ching
    Kelly, Shannon E.
    Chen, Li
    Skidmore, Becky
    Yousef, Said
    Zheng, Carine
    Stewart, David J.
    Wells, George A.
    PLOS ONE, 2020, 15 (02):
  • [45] The role of mitomycin in the treatment of non small cell lung cancer: a systematic review with meta-analysis of the literature
    Sculier, JP
    Ghisdal, L
    Berghmans, T
    Branle, F
    Lafitte, JJ
    Vallot, F
    Meert, AP
    Lemaitre, F
    Steels, E
    Burniat, A
    Mascaux, C
    Paesmans, M
    BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1150 - 1155
  • [46] Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Jiang, Juan
    Wang, Yuling
    Gao, Yang
    Sugimura, Haruhiko
    Minervini, Fabrizio
    Uchino, Junji
    Halmos, Balazs
    Yendamuri, Sai
    Velotta, Jeffrey B.
    Li, Min
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 277 - +
  • [47] Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients
    Nobuyuki Horita
    Masaki Yamamoto
    Takashi Sato
    Toshinori Tsukahara
    Hideyuki Nagakura
    Ken Tashiro
    Yuji Shibata
    Hiroki Watanabe
    Kenjiro Nagai
    Kentaro Nakashima
    Ryota Ushio
    Misako Ikeda
    Nobuaki Kobayashi
    Masaharu Shinkai
    Makoto Kudo
    Takeshi Kaneko
    Scientific Reports, 6
  • [48] Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis
    Kuo, Wei-Ke
    Weng, Ching-Fu
    Lien, Yin-Ju
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Chinese herbal medicine for small cell lung cancer patients A protocol for a systematic review and meta-analysis
    Mi, Xue
    Zhang, Xiwen
    He, Shulin
    Zhang, Zhenhua
    Qi, Runzhi
    Jiang, Juling
    Chen, Shuntai
    Zheng, Honggang
    Hua, Baojin
    MEDICINE, 2020, 99 (52)
  • [50] Risk Factors for Brain Metastasis in Patients with Small Cell Lung Cancer: A Systematic Review and Meta-analysis
    Zeng, H.
    Zheng, D.
    Witlox, W.
    Levy, A.
    Traverso, A.
    Kong, F. -M. S.
    Houben, R.
    De Ruysscher, D.
    Hendriks, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S532 - S532